Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ChiCTR-OPC-16008548
ChiCTR-OPC-16008548RecruitingPhase 4

右美托咪定在硬膜外分娩镇痛中的临床观察

Not provided1 site in 1 country80 target enrollmentStarted: April 24, 2016Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Enrollment
80
Locations
1
Primary Endpoint
视觉模拟评分
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

右美托咪定硬膜外分娩镇痛的可行性

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20 to 35 (—)
Sex
Female

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Case series

右美托咪定硬膜外

Intervention: 右美托咪定硬膜外

Outcomes

Primary Outcomes

视觉模拟评分

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Not provided

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
右美托咪啶在硬膜外分娩镇痛中的作用研究阴道分娩
ChiCTR-IPR-15006707自筹100
Unknown
Not Applicable
右美托咪定复合罗哌卡因用于硬膜外分娩镇痛的最适浓度分娩镇痛
ChiCTR1900021126医院支持150
Unknown
Not Applicable
小剂量右美托咪定滴鼻辅助硬膜外分娩镇痛的临床效果观察孕足月阴道分娩
ChiCTR2000033356合肥市第六周期重点培育专科项目（合卫科教〔2019〕160 号）;合肥市卫生计生委 2017 年应用医学研究项目（hwk2017zd003）60
Not yet recruiting
Unknown
右美托咪啶辅助用于罗哌卡因硬膜外分娩镇痛安全性及有效性的研究分娩痛
ChiCTR18000148491,200
Unknown
Not Applicable
右美托咪定和舒芬太尼联合罗哌卡因用于硬膜外镇痛分娩对产妇和新生儿影响的比较研究无痛分娩
ChiCTR2000038702成都市妇女儿童中心医院160